Choose Your News
Loading...
Thumbnail
Our slow progress against pancreatic cancer is representative of the war on cancer writ large. Focus in on pancreatic cancer, and you see that there... [Read More]
"I think in a few years I think everybody will know this number similar to the way we know our cholesterol right now," muses Sekar... [Read More]
Thumbnail
This morning, after 16 years and $2.5 billion in investment, the Cambridge, Mass.-based company Alnylam finally turned a 1998 biology breakthrough into a medicine: a... [Read More]
Thumbnail
A gene therapy being developed by RegenX Bio of Rockville, MD, showed early promise against wet macular degeneration, a leading cause of blindness. [Read More]
Thumbnail
This morning, Ovid Therapeutics, a small biotechnology company, is announcing data indicating that a drug, gaboxadol, may be of some help for patients with a... [Read More]
Thumbnail
Regeneron Pharmaceuticals, one of the largest biotechnology companies, and gene therapy upstart Bluebird Bio will team up to invent genetically modified white blood cells that... [Read More]
Thumbnail
Regeneron's Leonard Schleifer condemns greed at other drug firms. But what about the $37,000 price tag on his eczema drug? [Read More]
Thumbnail
GlaxoSmithKline, a London-based drug giant is partnering with 23andMe, the San Francisco genetics startup, to develop new medicines. The companies will split costs and profits... [Read More]
Thumbnail
GlaxoSmithCline is turning to a new chief scientific officer, Hal Barron, to reinvigorate its drug pipeline. [Read More]
Alice Zhang was a graduate student at UCLA when she decided that there was a tremendous opportunity to speed up the process of drug development.... [Read More]
The total number of companies splitting that cash pile has dropped, from 855 in the first six months of 2017 to 779 in the first... [Read More]
"At the end of the day the metric of our success as a business is going to be the number and quality of new medicines... [Read More]
A complicated new clinical trial could give some hope to Alzheimer's patients and investors in drug companies. But there are lots of devilish details. [Read More]
It's not that Gawande is not the perfect person for the job, but that choosing him gives the clearest indication yet of what the job... [Read More]
An experimental gene therapy appeared to dramatically increase the production of a muscle-making protein in three young boys with Duchenne muscular dystrophy, a deadly and... [Read More]
Bluebird Bio's experimental gene therapy LentiGlobin is helping some paitiens two life-threatening forms of inherited anemia avoid blood transfusions. [Read More]
The Bill & Melinda Gates Medical Research Institute, which is holding an event today to show off its plans, will aim to develop new medicines... [Read More]
Michael Becker used to be a biotech CEO. Now he wants people know about HPV, the vaccine-preventable virus that caused the cancer that spread from... [Read More]
Now on his fifth startup, Ned David has the blueprint for creating a lucrative biotech. His latest project: a company that will take on the... [Read More]
The annual meeting of the American Society of Clinical Oncology draws 45,000 doctors, researchers, and drug company executives to Chicago every year for a deluge... [Read More]
Loading...
Preview